New anticancer agents.
Weiss
G R
GR
Department of Medicine, University of Texas Health Science Center at San Antonio 78284-7884, USA.
Burris
H A
HA
Eckhardt
S G
SG
Rodriguez
G I
GI
Sharma
S
S
Valley
A
A
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D003606:Dacarbazine / Q000031:analogs & derivatives / Q000494:pharmacology; D006801:Humans; D007783:Lactones / Q000494:pharmacology; D018942:Macrolides; D009389:Neovascularization, Pathologic / Q000517:prevention & control; D013498:Suramin / Q000494:pharmacology; D000077204:Temozolomide; D013940:Thymidylate Synthase / Q000037:antagonists & inhibitors; D000077704:Tirapazamine; D014227:Triazines / Q000494:pharmacology; D014498:Uracil / Q000031:analogs & derivatives / Q000494:pharmacology
D000970:Antineoplastic Agents; D007783:Lactones; D018942:Macrolides; D014227:Triazines; D000077704:Tirapazamine; C073482:eniluracil; D014498:Uracil; D013498:Suramin; D003606:Dacarbazine; C041443:rhizoxin; D013940:Thymidylate Synthase; D000077204:Temozolomide